Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report

Scarfo' L.;Ferrari A.;
2021-01-01

2021
chronic lymphocytic leukemia
COVID-19
targeted agents
vaccination
Aged
COVID-19
Disease Management
Female
Humans
Italy
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Prognosis
SARS-CoV-2
Time Factors
Vaccination
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/124828
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact